Intellipharmaceutics International Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
43.54 M |
Public Float |
- |
Intellipharmaceutics International Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.32 |
Market Cap |
$15.4 M |
Shares Outstanding |
43.54 M |
Public Float |
- |
Address |
30 Worcester Road Toronto Ontario M9W 5X2 Canada |
Employees | - |
Website | http://www.intellipharmaceutics.com |
Updated | 09/14/2018 |
Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of existing and new pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes and pain. The company was founded by Isa Odidi and Amina Odidi on October 22, 2009 and is headquartered in Toronto, Canada. |